ERJ Open Research (Sep 2020)
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
- Alexander G. Mathioudakis,
- Fekri Abroug,
- Alvar Agusti,
- Per Bakke,
- Konstantinos Bartziokas,
- Bianca Beghe,
- Andras Bikov,
- Thomas Bradbury,
- Guy Brusselle,
- Cordula Cadus,
- Courtney Coleman,
- Marco Contoli,
- Alexandru Corlateanu,
- Olga Corlateanu,
- Gerard Criner,
- Balazs Csoma,
- Alexander Emelyanov,
- Rosa Faner,
- Gustavo Fernandez Romero,
- Zeineb Hammouda,
- Peter Horváth,
- Arturo Garcia Huerta,
- Michael Jacobs,
- Christine Jenkins,
- Guy Joos,
- Olga Kharevich,
- Konstantinos Kostikas,
- Elena Lapteva,
- Zsofia Lazar,
- Joerg D. Leuppi,
- Carol Liddle,
- Alejandra López-Giraldo,
- Vanessa M. McDonald,
- Rune Nielsen,
- Alberto Papi,
- Isabel Saraiva,
- Galina Sergeeva,
- Agni Sioutkou,
- Pradeesh Sivapalan,
- Elizabeth Stovold,
- Hao Wang,
- Fuqiang Wen,
- Janelle Yorke,
- Paula R. Williamson,
- Jørgen Vestbo,
- Jens-Ulrik Jensen
Affiliations
- Alexander G. Mathioudakis
- Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
- Fekri Abroug
- Hospital Fattouma Bourguiba, Monastir, Tunisia
- Alvar Agusti
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain
- Per Bakke
- Department of Clinical Science, University of Bergen, Bergen, Norway
- Konstantinos Bartziokas
- Respiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece
- Bianca Beghe
- Section of Respiratory Diseases, Dept of Medicine, University of Modena and Reggio Emilia, Modena, Italy
- Andras Bikov
- Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
- Thomas Bradbury
- The George Institute for Global Health, University of New South Wales, Sydney, Australia
- Guy Brusselle
- Depts of Epidemiology and Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
- Cordula Cadus
- University Department of Medicine, Cantonal Hospital Basell and Liestal, Basell, Switzerland
- Courtney Coleman
- European Lung Foundation, Sheffield, UK
- Marco Contoli
- Research Center on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- Alexandru Corlateanu
- Dept of Respiratory Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova
- Olga Corlateanu
- Department of Internal Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova
- Gerard Criner
- Dept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- Balazs Csoma
- Dept of Pulmonology, Semmelweis University, Budapest, Hungary
- Alexander Emelyanov
- Dept of Respiratory Medicine and Allergy, North-Western Medical University, St Petersburg, Russian Federation
- Rosa Faner
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain
- Gustavo Fernandez Romero
- Dept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- Zeineb Hammouda
- Hospital Fattouma Bourguiba, Monastir, Tunisia
- Peter Horváth
- Dept of Pulmonology, Semmelweis University, Budapest, Hungary
- Arturo Garcia Huerta
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain
- Michael Jacobs
- Dept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- Christine Jenkins
- The George Institute for Global Health, University of New South Wales, Sydney, Australia
- Guy Joos
- Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
- Olga Kharevich
- Dept of Pulmonology and Tuberculosis, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus
- Konstantinos Kostikas
- Respiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece
- Elena Lapteva
- Dept of Pulmonology and Tuberculosis, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus
- Zsofia Lazar
- Dept of Pulmonology, Semmelweis University, Budapest, Hungary
- Joerg D. Leuppi
- University Department of Medicine, Cantonal Hospital Basell and Liestal, Basell, Switzerland
- Carol Liddle
- European Lung Foundation, Sheffield, UK
- Alejandra López-Giraldo
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), National Spanish Network for Respiratory Research (CIBERES), Barcelona, Spain
- Vanessa M. McDonald
- Dept of Respiratory and Sleep Medicine, Medical and Interventional Services, John Hunter Hospital, Hunter New England Local Health District, New Lambton Heights, Australia
- Rune Nielsen
- Department of Clinical Science, University of Bergen, Bergen, Norway
- Alberto Papi
- Research Center on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- Isabel Saraiva
- European Lung Foundation, Sheffield, UK
- Galina Sergeeva
- Dept of Respiratory Medicine and Allergy, North-Western Medical University, St Petersburg, Russian Federation
- Agni Sioutkou
- Respiratory Medicine Dept, University of Ioannina School of Medicine, Ioannina, Greece
- Pradeesh Sivapalan
- Section of Respiratory Medicine, Dept of Internal Medicine, Herlev-Gentofte Hospital, Hellerup, Denmark
- Elizabeth Stovold
- Cochrane Airways Group, Population Health Research Institute, St George's University of London, London, UK
- Hao Wang
- Dept of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China
- Fuqiang Wen
- Dept of Respiratory and Critical Care Medicine, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China
- Janelle Yorke
- School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
- Paula R. Williamson
- Liverpool Clinical Trials Centre, Dept of Biostatistics, University of Liverpool, Liverpool, UK
- Jørgen Vestbo
- Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
- Jens-Ulrik Jensen
- Section of Respiratory Medicine, Dept of Internal Medicine, Herlev-Gentofte Hospital, Hellerup, Denmark
- DOI
- https://doi.org/10.1183/23120541.00193-2020
- Journal volume & issue
-
Vol. 6,
no. 3
Abstract
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.